Suppr超能文献

一名患有小梁腺瘤和细胞学不确定病变患者的EIF1AX基因c.338-2A>T剪接位点突变

EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion.

作者信息

Castagna Maria Grazia, Pilli Tania, Maino Fabio, Marzocchi Carlotta, Cairano Giovanni Di, Cantara Silvia

机构信息

Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.

出版信息

Arch Endocrinol Metab. 2020 Apr;64(2):185-189. doi: 10.20945/2359-3997000000208. Epub 2020 Mar 27.

Abstract

The EIF1AX gene mutations have been recently associated with papillary thyroid carcinoma and anaplastic thyroid cancer. According with these reports, the gene as been considered as a drive gene for thyroid cancer development. However, the occurrence of these alterations in benign thyroid lesions is not known and is still under investigation. Some authors have already reported the presence of EIF1AX variants in follicular adenomas and hyperplastic nodules. Here, we describe for the first time a case of a man with the EIF1AX c.338-2A>T splice site mutation in an indeterminate FNA lesion with trabecular adenoma at final histology in the absence of other pathogenetic mutations, demonstrating that further studies are required to better understand EIF1AX role in the tumorigenesis of thyroid carcinoma.

摘要

EIF1AX基因突变最近被发现与甲状腺乳头状癌和间变性甲状腺癌有关。根据这些报道,该基因被认为是甲状腺癌发生发展的驱动基因。然而,这些改变在良性甲状腺病变中的发生率尚不清楚,仍在研究中。一些作者已经报道在滤泡性腺瘤和增生性结节中存在EIF1AX变异。在此,我们首次描述了一例男性患者,其在最终组织学检查中为不确定的细针穿刺活检(FNA)病变伴小梁状腺瘤,存在EIF1AX c.338-2A>T剪接位点突变,且不存在其他致病突变,这表明需要进一步研究以更好地了解EIF1AX在甲状腺癌发生中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b64/10118949/3c8f1a623799/2359-4292-aem-64-02-0185-gf01.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验